ALS Ltd
OTC:CPBLF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
ALS Ltd
OTC:CPBLF
|
AU |
|
A
|
Aytu Biopharma Inc
F:AY20
|
US |
|
P
|
PostNL NV
XMUN:TNTC
|
NL |
|
AnaptysBio Inc
NASDAQ:ANAB
|
US |
|
G
|
Gazprom Neft' PAO
XBER:SCF
|
RU |
Wall St Price Targets
CPBLF Price Targets Summary
ALS Ltd
According to Wall Street analysts, the average 1-year price target for CPBLF is 18.768 USD with a low forecast of 14.108 USD and a high forecast of 21.962 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CPBLF's stock price target?
Price Target
18.768
USD
According to Wall Street analysts, the average 1-year price target for CPBLF is 18.768 USD with a low forecast of 14.108 USD and a high forecast of 21.962 USD.
What is the Revenue forecast for ALS Ltd?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 9%.
What is the Gross Profit forecast for ALS Ltd?
Projected CAGR
-8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 8 years is -8%.
What is the Operating Income forecast for ALS Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 12%.
What is the Pre-Tax Income forecast for ALS Ltd?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 24%.
What is the Net Income forecast for ALS Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 8 years is 13%.
